Literature DB >> 6309792

Calcium-dependent proteolysis occurs during platelet aggregation.

J E Fox, C C Reynolds, D R Phillips.   

Abstract

Control and stimulated platelets were analyzed by two-dimensional polyacrylamide gel electrophoresis to determine whether proteins are altered during platelet activation. Platelets were stimulated with thrombin, collagen, or the calcium ionophore A23187, and aggregation was brought about by stirring in the presence of Ca2+. These activated platelets contained at least three polypeptides not found in control platelets: 1) Mr = 200,000, pI between 6.2 and 6.4; 2) Mr = 100,000, pI = 6.3; and 3) Mr = 91,000, pI = 6.1. An additional polypeptide, polypeptide 4, with Mr = 97,000 and pI = 5.9, was present only in platelets activated by thrombin. When aggregation was prevented, either by adding 5 mM ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) to the platelet suspension or by incubating the platelet suspension without stirring, polypeptides 1-3 were not formed. Partial hydrolysis of polypeptides 2 and 4 with Staphylococcus aureus V8 protease yielded distinct sets of peptide hydrolytic fragments. These differed from those produced by the hydrolysis of alpha-actinin, a major platelet protein, which has a molecular weight similar to polypeptides 2 and 4. Polypeptides 1-3 were also produced during incubation of platelet lysates in the presence of Ca2+. Generation of these polypeptides in lysates was prevented either by chelation of Ca2+ with EGTA or by the addition of N-ethylmaleimide, leupeptin, or mersalyl, inhibitors of the calcium-dependent protease. These data show that the calcium-dependent protease is activated during aggregation of platelets by physiological agents and suggest that this protease could have a role in platelet response to stimulation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6309792

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Inhibition of calpain blocks platelet secretion, aggregation, and spreading.

Authors:  K Croce; R Flaumenhaft; M Rivers; B Furie; B C Furie; I M Herman; D A Potter
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

2.  Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.

Authors:  J Anagli; J Hagmann; E Shaw
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

3.  The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence.

Authors:  J A Lopez; D W Chung; K Fujikawa; F S Hagen; E W Davie; G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Calpain I remains intact and intracellular during platelet activation. Immunochemical measurements with monoclonal and polyclonal antibodies.

Authors:  J A Samis; G Zboril; J S Elce
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

5.  Linkage of a membrane skeleton to integral membrane glycoproteins in human platelets. Identification of one of the glycoproteins as glycoprotein Ib.

Authors:  J E Fox
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

6.  Multiple forms of phosphoinositide-specific phospholipase C of different relative molecular masses in animal tissues. Evidence for modification of the platelet enzyme by Ca2+-dependent proteinase.

Authors:  M G Low; R C Carroll; W B Weglicki
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

7.  Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein.

Authors:  J A Lopez; D W Chung; K Fujikawa; F S Hagen; T Papayannopoulou; G J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  Cytoskeletal domains in the activated platelet.

Authors:  E L Bearer
Journal:  Cell Motil Cytoskeleton       Date:  1995

Review 9.  Protein degradation systems in platelets.

Authors:  B F Kraemer; A S Weyrich; S Lindemann
Journal:  Thromb Haemost       Date:  2013-09-19       Impact factor: 5.249

10.  myo-Inositol 1,4,5-trisphosphate stimulates protein phosphorylation in saponin-permeabilized human platelets.

Authors:  E G Lapetina; S P Watson; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.